Skip to content

Article/Intelligence

Blackstone Considers Sale of HealthEdge

Share on X (opens in a new window) Share on Facebook (opens in a new window) Share on LinkedIn (opens in a new window)

Reporting: Armie Margaret Lee, Emily Fasold, Paola Aurisicchio, Dayna Fields


Blackstone Inc. is exploring a sale of healthcare technology company HealthEdge Software Inc., according to industry sources.

Based in Burlington, Mass., HealthEdge provides software to health insurers.

Blackstone’s growth equity group led the purchase of a majority stake in HealthEdge in 2020 in a transaction that reportedly valued the business at approximately $700 million, including debt.

Under Blackstone’s ownership, HealthEdge’s acquisitions include payment integrity software business The Burgess Group LLC and Martis Capital Management LLC-backed payor care management software company Altruista Health Inc. in 2020 and digital health management firm Wellframe Inc. in 2021.

HealthEdge has first lien debt maturing in July 2031, priced at SOFR+475 bps, that is owned by Ares Capital Corp., Franklin Bsp Capital Corp. and Goldman Sachs BDC Inc., among others, according to Octus’ BDC Database.

Bloomberg reported in 2022 that Blackstone was considering options for HealthEdge, including a potential stake sale that could give the portfolio company a valuation of about $3 billion. HealthEdge was projected to generate $400 million in revenue and $60 million in earnings in 2023, according to the report.

Recent deal activity in the broader healthcare technology sector includes Francisco Partners’ sale of pharmacy software company RedSail Technologies LLC to Leonard Green & Partners, with Francisco reinvesting in the business, and GTCR LLC’s sale of RevSpring Inc., a provider of billing and communications products to healthcare and financial services companies, to Frazier Healthcare Partners for about $1.4 billion.

Representatives for Blackstone and HealthEdge did not immediately respond to requests for comment.

This publication has been prepared by Octus, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2025 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.